Hudson Bay Capital Amends Helius Medical Stake, Below 5% Threshold

TL;DR

**Hudson Bay Capital Management LP is out of Helius Medical's 5%+ club, signaling a reduced stake.**

AI Summary

Hudson Bay Capital Management LP filed an amended SC 13G/A on February 5, 2024, indicating a change in their ownership of Helius Medical Technologies, Inc. Class A Common Stock as of December 31, 2023. This filing, an amendment to a previous Schedule 13G, signals that Hudson Bay Capital Management LP is no longer required to report their beneficial ownership under Rule 13d-1(b), likely due to their ownership falling below the 5% threshold. This matters to investors because it suggests a reduction in a significant institutional holder's stake, which could be interpreted as a lack of conviction or a strategic portfolio adjustment.

Why It Matters

This filing indicates a major institutional investor, Hudson Bay Capital Management LP, has reduced its stake in Helius Medical Technologies, Inc., potentially signaling a shift in their investment strategy or outlook on the company.

Risk Assessment

Risk Level: medium — A significant institutional investor reducing its stake can sometimes precede further stock price declines if other investors interpret it negatively.

Analyst Insight

Investors should monitor Helius Medical Technologies, Inc.'s stock for further institutional ownership changes and consider the implications of a major holder reducing its stake, potentially re-evaluating their own position.

Key Players & Entities

• Hudson Bay Capital Management LP (company) — the reporting person filing the SC 13G/A
• Helius Medical Technologies, Inc. (company) — the issuer of the Class A Common Stock
• December 31, 2023 (date) — the date of the event requiring the filing
• Class A Common Stock (company) — the type of securities held by Hudson Bay Capital Management LP
• $0.001 (dollar_amount) — par value per share of Helius Medical Technologies, Inc. Class A Common Stock

Forward-Looking Statements

• Helius Medical Technologies, Inc. stock may experience increased selling pressure or a lack of institutional support. (Helius Medical Technologies, Inc.) — medium confidence, target: Q1 2024

FAQ

Key Financial Figures

• $0.001 — suer) Class A Common Stock, par value $0.001 per share (Title of Class of Securitie

Filing Documents

• hsdt_13ga.htm (SC 13G/A) — 52KB
• image_019.gif (GRAPHIC) — 0KB
• 0001393825-24-000063.txt ( ) — 55KB

(a)

Item 1(a). NAME OF ISSUER: The name of the issuer is Helius Medical Technologies, Inc., a Delaware corporation (the " Company ").

(b)

Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: The Company's principal executive offices are located at 642 Newtown Yardley Road, Suite 100, Newtown, Pennsylvania 18940.

(a)

Item 2(a). NAME OF PERSON FILING: This statement is filed by Hudson Bay Capital Management LP (the " Investment Manager ") and Mr. Sander Gerber (" Mr. Gerber "), who are collectively referred to herein as " Reporting Persons ."

(b)

Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: The address of the business office of each of the Reporting Persons is 28 Havemeyer Place, 2nd Floor, Greenwich, Connecticut 06830.

(c)

Item 2(c). CITIZENSHIP: The Investment Manager is a Delaware limited partnership. Mr. Gerber is a United States citizen.

(d)

Item 2(d). TITLE OF CLASS OF SECURITIES: Class A common Stock, par value $0.001 per share (the " Class A Common Stock ").

(e)

Item 2(e). CUSIP NUMBER: 42328V801 Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) ý Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) ¨ Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) ý Parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) ¨ Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) ¨ Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3); (j) ¨ Non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentages used in this Schedule 13G/A are calculated based upon 708,247 shares of Class A Common Stock outstanding as of November 3, 2023, as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 filed with the Securities and Exchange Commission on November 9, 2023, and assumes the exercise of the reported warrants. The Investment Manager serves as the inv

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of its or his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. DATE: February 5, 2024 HUDSON BAY CAPITAL MANAGEMENT LP By: /s/ Sander Gerber Name:Sander Gerber Title:Authorized Signatory /s/ Sander Gerber SANDER GERBER

View Full Filing

View this SC 13G/A filing on SEC EDGAR